Lisset Casanueva
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 118 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations.
Across 118 payments — averaging $21.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$507
- AstraZeneca$357
- Amgen$292
- Boehringer Ingelheim$182
- Sumitomo Pharma America, Inc.$157
- Pfizer$136
- plus $856 from 17 others
What the payments were for
- Food & beverage$2,486100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 25 | $507 |
| AstraZeneca(2 entities) | 14 | $357 |
| Amgen | 20 | $292 |
| Boehringer Ingelheim | 7 | $182 |
| Sumitomo Pharma America, Inc. | 7 | $157 |
| Pfizer | 5 | $136 |
| Exact Sciences | 5 | $117 |
| Johnson & Johnson(2 entities) | 5 | $87 |
| GSK | 4 | $83 |
| AbbVie | 4 | $77 |
| Ardelyx, Inc. | 3 | $65 |
| Novartis | 2 | $58 |
| Dexcom, Inc. | 3 | $57 |
| Astellas Pharma US Inc | 2 | $54 |
| Novo Nordisk | 2 | $39 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $38 |
| Radius Health, Inc. | 1 | $33 |
| Esperion Therapeutics, Inc. | 2 | $33 |
| Heartflow, Inc. | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Bayer | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
How this compares
$2,486 in reported general payments places this provider in the 85th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 36 | $737 |
| Lidocaine | 12 | $577 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 44 | $456 |
| Rosuvastatin Calcium | 36 | $377 |
| Levothyroxine Sodium | 36 | $359 |
| Diclofenac Sodium | 22 | $314 |
| Azithromycin | 76 | $309 |
| Methylprednisolone | 42 | $304 |
| Omeprazole | 20 | $270 |
| Amlodipine Besylate | 45 | $266 |
| Cefdinir | 18 | $225 |
| Atorvastatin Calcium | 26 | $196 |
| Doxycycline Hyclate | 25 | $161 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 28 | $141 |
| Pantoprazole Sodium | 14 | $139 |
Paid to pharmacies, not to this prescriber.
Other family in Miami
- Patrick SzarazMiami$327K
- Yamila MelendezMiami$212K
- Suzan RosenMiami$129K
- Felipe NovoaMiami$110K
- Pamela DudkiewiczMiami$89K
- Stacy FeemsterMiami$51K
- Estrella Moreno RodriguezMiami$30K
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.